Nasty US measles outbreak helps boost Merck's vaccine sales in second quarter - CNBC

Nasty US measles outbreak helps boost Merck's vaccine sales in second quarter  CNBC

Sales of children vaccines, which includes the New Jersey-based company's MMR vaccine for measles, jumped 58% year-over-year to $675 million, Merck ...



Comments

Popular Posts

UKHSA Advisory Board: preparedness for infectious disease threats